(59 days)
The Ansell or private label black condom is a male contraceptive device, fabricated of latex, which is designed to completely cover the penis during sexual intercourse. This condom is intended to be used for contraceptive and prophylactic purposes. If used properly, this condom will help reduce the risk of transmission of HIV infection (AIDS) and many other sexually transmitted diseases including chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. In addition, this condom will help reduce the risk of pregnancy without the serious side effects sometimes associated with other methods. However, no contraceptive can guarantee 100% effectiveness. Failure to use as directed may further result in loss of protection. Furthermore, sexually transmitted diseases can be transmitted through lesions and various body fluids during intimate contact. Therefore, the condom should be applied before any such contact.
This condom is a male contraceptive and prophylactic device which is fabricated of a natural rubber latex. The condom is designed as a fitted sheath with an integral ring at the open end and a reservoir at the closed end to contain semen. This condom is designed to conform to established national and international voluntary standards including ASTM D3492, ISO 4074, and EN 600.
The provided document is a 510(k) Pre-market Notification for a latex condom, and as such, it focuses on demonstrating substantial equivalence to a predicate device rather than presenting a study of its effectiveness against a set of acceptance criteria in the way medical diagnostic or AI-driven devices typically would.
Therefore, the information requested in your prompt regarding acceptance criteria, device performance, sample sizes for test/training sets, experts, adjudication methods, multi-reader studies, and ground truth types is not explicitly detailed within this regulatory submission.
However, I can extract the information related to conformance with required specifications and physical testing which implies a form of acceptance criteria and performance evaluation.
Here's an attempt to answer your request based on the available information, noting the absence of detail for many of your points:
-
Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria (Implied) Reported Device Performance Conformance to ASTM D3492 standards "revealed results in conformance with required specifications" Conformance to ISO 4074 standards "revealed results in conformance with required specifications" Conformance to EN 600 standards "revealed results in conformance with required specifications" Biocompatibility: Not toxic (local or systemic) "The condom is not toxic (local or systemic)" Biocompatibility: Not sensitizing "not sensitizing" Biocompatibility: Not locally irritating "not locally irritating" Biocompatibility: Not otherwise harmful "not otherwise harmful" Colorfastness "revealed results in conformance with required specifications" Air inflation testing "revealed results in conformance with required specifications" Other in-process and final release testing (physical properties) "revealed results in conformance with required specifications" -
Sample sizes used for the test set and the data provenance: Not explicitly stated. The document mentions "All physical testing, air inflation testing, colorfastness testing, including other in-process and final release testing." The provenance would be from manufacturing batches of the device, likely from India where the manufacturer is located. It is an intrinsic part of the manufacturing quality control process, not a separate clinical "test set" in the sense of a diagnostic device.
-
Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. The "ground truth" for condom performance in this context refers to adherence to international and national standards for physical properties and biocompatibility. This is assessed through laboratory testing, not expert interpretation of results.
-
Adjudication method for the test set: Not applicable. Laboratory testing against predefined standards does not typically involve adjudication in the expert consensus sense.
-
If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This device is a physical product (condom), not an AI-driven diagnostic tool or imaging system.
-
If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable for a physical device like a condom.
-
The type of ground truth used:
- External Standards: ASTM D3492, ISO 4074, and EN 600 for physical properties.
- Biocompatibility Standards: Methods of ISO 10993 Biological Evaluation of Medical Devices and ODE Guidance Memorandum G95-1 (for 24 hours or less contact with skin/mucosal membrane).
-
The sample size for the training set: Not applicable. There is no "training set" in the context of a physical product's regulatory submission for demonstrating substantial equivalence. All testing mentioned relates to quality control and final product verification against established standards.
-
How the ground truth for the training set was established: Not applicable.
{0}------------------------------------------------
AUG 19 1999
2992081 pg.1of2
II. 510(k) SUMMARY
| Submitted by: | Suretex Prophylactics (India) Limited74-91, KIADB Industrial EstateJigani II Phase, Anekal TalukBangalore - 562 106IndiaTelephone: 91-80-426-222Fax: 91-80-426-219 | |
|---|---|---|
| Contact Person: | Dr. V. V. Ramana Rao | |
| Date Prepared: | June 2, 1999 | |
| Proprietary Name: | Ansell trade names (LifeStyles, Midnight) orprivate label - silicone lubricated - black color | |
| Common Name: | Latex condom | |
| Classification Name: | Condom (21 CFR §884.5300) | |
| Predicate Device: | Suretex Prophylactics (India) Limited, Royale® BrandLatex Condoms(Silicone) Natural or Assorted Colors510(k) Document Control Number K983320Sime Health Ltd., Lubricated (Silicone) LatexCondom (Coloured)510(k) Document Control Number K932983 |
Description of the Device:
This condom is a male contraceptive and prophylactic device which is fabricated of a natural rubber latex. The condom is designed as a fitted sheath with an integral ring at the open end and a reservoir at the closed end to contain semen. This condom is designed to conform to established national and international voluntary standards including ASTM D3492, ISO 4074, and EN 600.
Intended Use of the Device:
This condom has the same intended use as the predicate condoms. The condom is used for contraception and for prophylactic purposes. If used properly, these condoms will help reduce the risk of transmission of HIV infection (AIDS) and many other sexually transmitted diseases including chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. In addition, these condoms will help reduce the risk of pregnancy without the serious side effects sometimes
{1}------------------------------------------------
K 992081
Pg 2 of 2
associated with other methods. However, no contraceptive can guarantee 100% effectiveness. Failure to use as directed may further result in loss of protection. Furthermore, sexually transmitted diseases can be transmitted through lesions and various body fluids during intimate contact. Therefore, the condoms should be applied before any such contact.
Technological Characteristics:
The design, composition (natural rubber latex) and manufacture of this condom are the same as the predicate male latex condoms except for the pigment used for coloring the product. The condom design conforms to domestic and international regulations: ASTM D3492, ISO 4074, and EN 600. All physical testing, air inflation testing, colorfastness testing, including other in-process and final release testing, revealed results in conformance with required specifications.
The High Purity Furnace Black (CAS Reg. No. 1333-86-4) "colorant supplied to Ansell and/or Suretex was approved effective May 9, 1997 as a colorant for polymers (CFR $178.3297). This black colorant is formulated into an aqueous dispersion called Permablak 2949 for use in coloring the compounded latex formulation.
Biocompatibility testing of the finished condom has been conducted in conformance with test methods of ISO 10993 Biological Evaluation of Medical Devices and ODE Guidance Memorandum G95-1 dated May 1, 1995, for a Device in Contact for 24 hours or less with a Skin/Mucosal Membrane Surface. The condom is not toxic (local or systemic), sensitizing, locally irritating or otherwise harmful.
Therefore, when compared to the predicate male latex condoms, the condom did not incorporate any significant changes in intended use, method of operations. materials, or design that could affect safety and effectiveness.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes representing the department's mission. The text "U.S. Department of Health & Human Services - USA" is arranged in a circular pattern around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 1 9 1999
Suretex Prophylactics (India) LTD. c/o Mr. Lon D. McIlvain Quality Assurance/Regulatory Manager Ansell Healthcare Products Inc. 1500 Industrial Road Post Office Box 1252 Dothan, Alabama 36302
Re: K992081
LifeStyles® and Tuxedo® Black Color Male Latex Condoms Dated: June 18, 1999 Received: June 21, 1999 Regulatory Class: II 21 CFR §884.5300/Procode: 85 HIS
Dear Mr. McIlvain:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
{3}------------------------------------------------
Page 2 - Mr. Lon D. McIlvain
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market
Please be advised that, as of March 25, 1998, labeling for latex condoms (21 CFR 884.5300 and 884.5310) must comply with Use Labeling for Latex Condoms: Expiration Dating, 21 CFR 801.435. Therefore, an expiration date, supported by test data developed under the conditions specified in 801.435(d), must be displayed prominently and legibly on condom labeling. For condoms with spermicidal lubricant, the effective shelf life of the spermicide must be compared with the shelf life of the condom and labeled with the earlier of the two expiration dates. Although supporting data is not to be provided in your 510(k) submission, 801.435(i) requires that you maintain this data and that it be available for inspection by FDA. Furthermore, 801. 435(e) requires that if your real-time test data fails to confirm the shelf life estimated by the methods in 801.435(d), then you must relabel all product to reflect the actual shelf life. Condoms are not to be labeled with an expiration date that gives a shelf life more than five years.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4616. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number: (800) 638-2041 or (301) 443-6597, or at its Internet address: "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours.
sincerely yours,
[signature]
CAPT. Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal. Ear. Nose and Throat. and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
{4}------------------------------------------------
INDICATIONS FOR USE STATEMENT
None assigned as of this time 510(k) Number:
Device Name:
Various Ansell or private label tradename male latex condoms with silicone lubricant - black color
Indications for Use:
The Ansell or private label black condom is a male contraceptive device, fabricated of latex, which is designed to completely cover the penis during sexual intercourse. This condom is intended to be used for contraceptive and prophylactic purposes. If used properly, this condom will help reduce the risk of transmission of HIV infection (AIDS) and many other sexually transmitted diseases including chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. In addition, this condom will help reduce the risk of pregnancy without the serious side effects sometimes associated with other methods. However, no contraceptive can guarantee 100% effectiveness. Failure to use as directed may further result in loss of protection. Furthermore, sexually transmitted diseases can be transmitted through lesions and various body fluids during intimate contact. Therefore, the condom should be applied before any such contact.
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use(Per 21 CFR §801.109) | OR Over-The-Counter Use |
|---|---|
| ------------------------------------------- | ------------------------- |
(Division Sign-Off)
Division of Reproductive, Abdominal, ENT,
and Radiological Devices
510(k) Number K992081
§ 884.5300 Condom.
(a)
Identification. A condom is a sheath which completely covers the penis with a closely fitting membrane. The condom is used for contraceptive and for prophylactic purposes (preventing transmission of sexually transmitted infections). The device may also be used to collect semen to aid in the diagnosis of infertility.(b)
Classification. (1) Class II (special controls) for condoms made of materials other than natural rubber latex, including natural membrane (skin) or synthetic.(2) Class II (special controls) for natural rubber latex condoms. The guidance document entitled “Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300” will serve as the special control. See § 884.1(e) for the availability of this guidance document.